Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Diabetes
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Under the Lens: Progression of Diabetic Retinopathy and the Impact of Fenofibrate
October 2024
With an increasing prevalence of diabetic retinopathy, a cause of vision impairment and blindness in those with diabetes, there is a need…
Read more
31st October 2024
Under the Lens: Progression of Diabetic Retinopathy and the Impact of Fenofibrate
With an increasing prevalence of diabetic retinopathy, a cause of vision impairment and blindness in those with diabetes, there is a need…
6
Mins
25th October 2024
Interview: Samuel Seidu
The main findings of the paper revealed that Black patients were underrepresented in clinical trials, particularly with respect to the newer diabetes therapies, sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists.
5
Mins
25th October 2024
The Impact of Gestational Diabetes on Long-Term Kidney Disease
Gestational diabetes mellitus (GDM) is a pervasive metabolic disorder associated with a spectrum of long-term adverse outcomes. Recent…
6
Mins
25th October 2024
Consequences of Disintegrated Care for Dual Tuberculosis and Diabetes
Diabetes is known to be a risk factor for active pulmonary tuberculosis (TB) and the reactivation of latent or previous TB. It is also…
5
Mins
3rd October 2024
Interview: Philippe Froguel
Today, the priority populations to target to prevent diabetes should be young adults who have inadequate diets. This information should guide public health action to prevent diabetes.
8
Mins
1st October 2024
Hyperkalemic Paralysis by Addisonian Crisis: A Near Fatal Accident
This case report presents an unusual clinical scenario where a patient experienced temporary paralysis of his lower limbs while driving…
3
Mins
23rd August 2024
No Bolusing with Closed Loop
This article reviews real-world data presented at the ADA Scientific Sessions 2024. It demonstrates the glycaemic range when Control-IQ Technology users do not manually bolus for extended periods
5
Mins
22nd August 2024
A Case of Mauriac Syndrome Caused by Social Inequities in Healthcare: A Call to Action
A 21-year-old female with a history of Type 1 diabetes mellitus (T1DM) with baseline HbA1c ranging from 8.8–12.5%, delayed menarche…
Loading posts...
1
2
3
…
16
Next »